TY - JOUR
T1 - Updating the OMERACT filter: core areas as a basis for defining core outcome sets
AU - Kirwan, John R.
AU - Boers, Maarten
AU - Hewlett, Sarah
AU - Beaton, Dorcas
AU - Bingham, Clifton O.
AU - Choy, Ernest
AU - Conaghan, Philip G.
AU - D'Agostino, Maria-Antonietta
AU - Dougados, Maxime
AU - Furst, Daniel E.
AU - Guillemin, Francis
AU - Gossec, Laure
AU - van der Heijde, Désirée M.
AU - Kloppenburg, Margreet
AU - Kvien, Tore K.
AU - Landewé, Robert B. M.
AU - Mackie, Sarah L.
AU - Matteson, Eric L.
AU - Mease, Philip J.
AU - Merkel, Peter A.
AU - Ostergaard, Mikkel
AU - Saketkoo, Lesley Ann
AU - Simon, Lee
AU - Singh, Jasvinder A.
AU - Strand, Vibeke
AU - Tugwell, Peter
AU - Furst, DE
PY - 2014
Y1 - 2014
N2 - The Outcome Measures in Rheumatology (OMERACT) Filter provides guidelines for the development and validation of outcome measures for use in clinical research. The "Truth" section of the OMERACT Filter presupposes an explicit framework for identifying the relevant core outcomes that are universal to all studies of the effects of intervention effects. There is no published outline for instrument choice or development that is aimed at measuring outcome, was derived from broad consensus over its underlying philosophy, or includes a structured and documented critique. Therefore, a new proposal for defining core areas of measurement ("Filter 2.0 Core Areas of Measurement") was presented at OMERACT 11 to explore areas of consensus and to consider whether already endorsed core outcome sets fit into this newly proposed framework. Discussion groups critically reviewed the extent to which case studies of current OMERACT Working Groups complied with or negated the proposed framework, whether these observations had a more general application, and what issues remained to be resolved. Although there was broad acceptance of the framework in general, several important areas of construction, presentation, and clarity of the framework were questioned. The discussion groups and subsequent feedback highlighted 20 such issues. These issues will require resolution to reach consensus on accepting the proposed Filter 2.0 framework of Core Areas as the basis for the selection of Core Outcome Domains and hence appropriate Core Outcome Sets for clinical trials
AB - The Outcome Measures in Rheumatology (OMERACT) Filter provides guidelines for the development and validation of outcome measures for use in clinical research. The "Truth" section of the OMERACT Filter presupposes an explicit framework for identifying the relevant core outcomes that are universal to all studies of the effects of intervention effects. There is no published outline for instrument choice or development that is aimed at measuring outcome, was derived from broad consensus over its underlying philosophy, or includes a structured and documented critique. Therefore, a new proposal for defining core areas of measurement ("Filter 2.0 Core Areas of Measurement") was presented at OMERACT 11 to explore areas of consensus and to consider whether already endorsed core outcome sets fit into this newly proposed framework. Discussion groups critically reviewed the extent to which case studies of current OMERACT Working Groups complied with or negated the proposed framework, whether these observations had a more general application, and what issues remained to be resolved. Although there was broad acceptance of the framework in general, several important areas of construction, presentation, and clarity of the framework were questioned. The discussion groups and subsequent feedback highlighted 20 such issues. These issues will require resolution to reach consensus on accepting the proposed Filter 2.0 framework of Core Areas as the basis for the selection of Core Outcome Domains and hence appropriate Core Outcome Sets for clinical trials
U2 - https://doi.org/10.3899/jrheum.131309
DO - https://doi.org/10.3899/jrheum.131309
M3 - Article
C2 - 24634204
SN - 0315-162X
VL - 41
SP - 994
EP - 999
JO - Journal of rheumatology
JF - Journal of rheumatology
IS - 5
ER -